Back to Search
Start Over
ASR490, a Small Molecule, Overrides Aberrant Expression of Notch1 in Colorectal Cancer
- Source :
- Molecular Cancer Therapeutics. 19:2422-2431
- Publication Year :
- 2020
- Publisher :
- American Association for Cancer Research (AACR), 2020.
-
Abstract
- Notch1 activation triggers significant oncogenic signaling that manifests as enhanced metastatic potential and tumorigenesis in colorectal cancer. Novel small-molecule inhibitors, mainly plant-derived analogs, have low toxicity profiles and higher bioavailability. In this study, we have developed a small molecule, ASR490, by modifying structure of naturally occurring compound Withaferin A. ASR490 showed a growth-inhibitory potential by downregulating Notch1 signaling in HCT116 and SW620 cell lines. Docking studies and thermal shift assays confirmed that ASR490 binds to Notch1, whereas no changes in Notch2 and Notch3 expression were seen in colorectal cancer cells. Notch1 governs epithelial-to-mesenchymal transition signaling and is responsible for metastasis, which was abolished by ASR490 treatment. To further confirm the therapeutic potential of ASR490, we stably overexpressed Notch1 in HCT-116 cells and determined its inhibitory potential in transfected colorectal cancer (Notch1/HCT116) cells. ASR490 effectively prevented cell growth in both the vector (P = 0.005) and Notch1 (P = 0.05) transfectants. The downregulation of Notch1 signaling was evident, which corresponded with downregulation of mesenchymal markers, including N-cadherin and β-catenin and induction of E-cadherin in HCT-116 transfectants. Intraperitoneal administration of a 1% MTD dose of ASR490 (5 mg/kg) effectively suppressed the tumor growth in control (pCMV/HCT116) and Notch1/HCT116 in xenotransplanted mice. In addition, downregulation of Notch1 and survival signaling in ASR-treated tumors confirmed the in vitro results. In conclusion, ASR490 appears to be a potent agent that can inhibit Notch1 signaling in colorectal cancer.
- Subjects :
- 0301 basic medicine
Cancer Research
Cell growth
Colorectal cancer
Chemistry
Mesenchymal stem cell
Transfection
medicine.disease
medicine.disease_cause
In vitro
Metastasis
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Oncology
Downregulation and upregulation
hemic and lymphatic diseases
030220 oncology & carcinogenesis
embryonic structures
cardiovascular system
Cancer research
medicine
sense organs
biological phenomena, cell phenomena, and immunity
Carcinogenesis
Subjects
Details
- ISSN :
- 15388514 and 15357163
- Volume :
- 19
- Database :
- OpenAIRE
- Journal :
- Molecular Cancer Therapeutics
- Accession number :
- edsair.doi...........fb2389b2bdaad383725135e10511c315